Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 4 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.
Cancers (Basel). 2022 Dec 2;14(23):5966. doi: 10.3390/cancers14235966.
Cancers (Basel). 2022.
PMID: 36497447
Free PMC article.
Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis.
Leyh C, Ehmer U, Roessler D, Philipp AB, Reiter FP, Jeliazkova P, Jochheim LS, Jeschke M, Hammig J, Ludwig JM, Theysohn JM, Geier A, Lange CM.
Leyh C, et al. Among authors: jochheim ls.
Cancers (Basel). 2022 Apr 13;14(8):1975. doi: 10.3390/cancers14081975.
Cancers (Basel). 2022.
PMID: 35454881
Free PMC article.
Item in Clipboard
Toll-like receptor 3 expression in myeloid cells is essential for efficient regeneration after acute pancreatitis in mice.
Hidalgo-Sastre A, Kuebelsbeck LA, Jochheim LS, Staufer LM, Altmayr F, Johannes W, Steiger K, Ronderos M, Hartmann D, Hüser N, Schmid RM, Holzmann B, von Figura G.
Hidalgo-Sastre A, et al. Among authors: jochheim ls.
Eur J Immunol. 2021 May;51(5):1182-1194. doi: 10.1002/eji.202048771. Epub 2021 Mar 22.
Eur J Immunol. 2021.
PMID: 33521935
Free article.
Item in Clipboard
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study.
Roessler D, Öcal O, Philipp AB, Markwardt D, Munker S, Mayerle J, Jochheim LS, Hammer K, Lange CM, Geier A, Seidensticker M, Reiter FP, De Toni EN, Ben Khaled N.
Roessler D, et al. Among authors: jochheim ls.
J Cancer Res Clin Oncol. 2023 Jul;149(7):3065-3073. doi: 10.1007/s00432-022-04206-8. Epub 2022 Jul 21.
J Cancer Res Clin Oncol. 2023.
PMID: 35864269
Free PMC article.
Item in Clipboard
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience.
de Castro T, Jochheim LS, Bathon M, Welland S, Scheiner B, Shmanko K, Roessler D, Ben Khaled N, Jeschke M, Ludwig JM, Marquardt JU, Weinmann A, Pinter M, Lange CM, Vogel A, Saborowski A.
de Castro T, et al. Among authors: jochheim ls.
Ther Adv Med Oncol. 2022 Feb 26;14:17588359221080298. doi: 10.1177/17588359221080298. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 35251317
Free PMC article.
Item in Clipboard
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab.
Jeschke M, Ludwig JM, Leyh C, Pabst KM, Weber M, Theysohn JM, Lange CM, Herrmann K, Schmidt HH, Jochheim LS.
Jeschke M, et al. Among authors: jochheim ls.
Cancers (Basel). 2023 Aug 26;15(17):4274. doi: 10.3390/cancers15174274.
Cancers (Basel). 2023.
PMID: 37686549
Free PMC article.
Item in Clipboard
The neuropeptide receptor subunit RAMP1 constrains the innate immune response during acute pancreatitis in mice.
Jochheim LS, Odysseos G, Hidalgo-Sastre A, Zhong S, Staufer LM, Kroiss M, Kabacaoglu D, Lange S, Engleitner T, Hartmann D, Hüser N, Steiger K, Schmid RM, Holzmann B, von Figura G.
Jochheim LS, et al.
Pancreatology. 2019 Jun;19(4):541-547. doi: 10.1016/j.pan.2019.05.455. Epub 2019 May 11.
Pancreatology. 2019.
PMID: 31109903
Item in Clipboard
Cite
Cite